Skip to Main Content

Paper Details

DNA priming and gp120 boosting induces HIV-specific antibodies in a randomized clinical trial.
J Clin Invest
27
2019
Author NameAffiliation
Nadine RouphaelHope Clinic of the Emory Vaccine Center, Emory University
Ian FrankUniversity of Pennsylvania
Margaret Juliana McElrathFred Hutchinson Cancer Research Center
David C MontefioriDuke University Medical Center
Michael C KeeferUniversity of Rochester School of Medicine & Dentistry
  • 1 - 5

Datasets

Release 1.2